ReviewDefining Left Bundle Branch Block in the Era of Cardiac Resynchronization Therapy
Section snippets
Cardiac Resynchronization Therapy
In the presence of complete LBBB, there is a significant delay between activation of the interventricular septum and activation of the left ventricular (LV) free wall (Figure 1).1 Thus, decreasing the delay by simultaneous pacing of the septum and LV free wall may resynchronize mechanical contraction. However, in the presence of QRS prolongation due to right bundle branch block (RBBB) or LVH, the LV endocardium is activated normally via the rapidly conducting Purkinje system.1
The major
Early History of Defining Bundle Branch Block
Eppinger and Rothberger9 created the first experimental bundle branch block in dogs in 1909 by injecting silver nitrate into the left ventricle. In 1914, Carter10 published the first series of patient electrocardiograms with bundle branch block and observed that RBBB was more common than LBBB, but he mistakenly switched the diagnosis of LBBB and RBBB, which was later attributed to differences in heart position between the dog and the human.11 In 1920, Wilson and Herrmann12 presented criteria
Challenges to the Definition of Left Bundle Branch Block
In 1956, Grant and Dodge16 studied 128 patients with QRS durations ≥120 ms and LV conduction delays who had an electrocardiograms showing normal conduction within the previous 2 years (<6 months in 80%). Their conclusion was that “the classical explanation of LBBB, which is based upon animal experimentation, is only partially accurate when applied to human LBBB,” and they proposed that 1/3 of electrocardiograms classified as LBBB by conventional criteria were incorrectly diagnosed.16 This was
Endocardial Mapping of Patients With Left Bundle Branch Block by Conventional Criteria
In 1984, Vassallo et al19 performed endocardial catheter mapping in 18 patients with LBBB by conventional ECG criteria. Twelve patients had 1 septal site of LV endocardial breakthrough. The other 6 had 2 LV endocardial breakthrough sites, often 1 septal and 1 at the superior base, consistent with 2 of the 3 sites of endocardial breakthrough in normal hearts. This suggests that 1/3 of patients classified by conventional criteria to have LBBB did not actually have complete LBBB, just as Grant and
Defining Complete Left Bundle Branch Block
Conventional criteria for LBBB that are used clinically include a QRS duration ≥120 ms, QS or rS in lead V1, and a monophasic R wave with no Q waves in leads V6 and I.23 The American Heart Association, American College of Cardiology Foundation, and Heart Rhythm Society recommendations do go beyond this to include “broad notched or slurred R wave in leads I, aVL, V5 and V6 and an occasional RS pattern in V5 and V6 attributed to displaced transition of the QRS complex.”24 We strongly support that
References (28)
- et al.
The QRS complex—a biomarker that “images” the heart: QRS scores to quantify myocardial scar in the presence of normal and abnormal ventricular conduction
J Electrocardiol
(2009) - et al.
Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials
Heart Rhythm
(2005) - et al.
The excitatory process observed in the exposed human heart
Am Heart J
(1930) - et al.
Mechanisms of QRS complex prolongation in man; left ventricular conduction disturbances
Am J Med
(1956) - et al.
Left ventricular endocardial activation during right ventricular pacing: effect of underlying heart disease
J Am Coll Cardiol
(1986) - et al.
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology
J Am Coll Cardiol
(2009) - et al.
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Heart Rhythm
(2011) - et al.
ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis
Circ Arrhythm Electrophysiol
(2008) - et al.
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
N Engl J Med
(2004) - et al.
The effect of cardiac resynchronization on morbidity and mortality in heart failure
N Engl J Med
(2005)
Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in medicare patients
Circulation
Cardiac-resynchronization therapy for the prevention of heart-failure events
N Engl J Med
CRT-D effectiveness by QRS duration and morphology in the MADIT-CRT patients
Heart Rhythm
Zur Analyse des Elektrokardiograms
Wien Klin Wschnschr
Cited by (0)
After completion of this report, Dr. Strauss moved to the United States Food and Drug Administration. The views expressed do not represent those of the Food and Drug Administration.